Literature DB >> 29507723

Extrapleural pneumonectomy of recurrent thymoma with pleural dissemination.

Haruhiko Shiiya1, Yasuhiro Hida1, Kichizo Kaga1, Rei Inoue1, Reiko Nakada-Kubota1, Yoshiro Matsui1.   

Abstract

Complete surgical resection has been considered the only curable treatment for thymoma. The efficacy of extrapleural pneumonectomy (EPP) for stage IV thymomas remains controversial. In this case report, we utilize EPP for recurrent thymoma with pleural dissemination and describe the resulting outcome. A 39-year-old female with a history of thoracoscopic thymectomy for type B2 thymoma was referred to our hospital for a recurrence of thymoma with pleural dissemination. She underwent EPP as a radical surgery. Histopathological investigation revealed complete resection. The postoperative course was uneventful. She returned to her full-time job and showed no sign of recurrence at 31 months after surgery. EPP for recurrent thymoma with pleural dissemination may be considered to achieve macroscopically complete resection when the patient is young and has a sufficient pulmonary function reservoir without preoperative complications.

Entities:  

Keywords:  Mediastinal tumour; mediastinum; pleural dissemination; thymoma

Year:  2018        PMID: 29507723      PMCID: PMC5830062          DOI: 10.1002/rcr2.308

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


Introduction

Complete surgical resection has been considered the only curable treatment for thymoma. Although some reports describe the efficacy of extrapleural pneumonectomy (EPP) for stage IV thymomas in limited cases, its efficacy remains controversial 1, 2, 3. Only a few published reports examined EPP for pleural dissemination following thymectomy 1, 2, 3, 4. Previous studies that examined EPP for recurrent thymomas with pleural dissemination described only recurrence and survival rates after EPP, with no description of the postoperative course or the quality of life. In this case report, we utilize EPP for recurrent thymoma with pleural dissemination and describe the resulting outcome.

Case Report

A 39‐year‐old asymptomatic female with a history of thoracoscopic thymectomy for type B2 thymoma was referred to a local general hospital for an abnormal left mediastinal shadow detected on a chest X‐ray. All of the laboratory tests were normal. A chest computed tomography (CT) scan showed disseminated tumours on the left parietal, mediastinal, and visceral pleurae, with possible invasion into the lungs and pericardium (Fig. 1). A percutaneous needle biopsy revealed recurrence of the thymoma. A positron emission tomography (PET)‐CT scan demonstrated fluorodeoxyglucose (FDG) uptake in disseminated tumours (Fig. 2) and no evidence of distant metastasis. She was referred to our department and underwent EPP. The patient was placed in the right lateral decubitus position, and a left lateral thoracotomy was performed through the seventh rib bed. The third rib and the intercostal muscle, which was used as an access port in a previous operation on the primary tumour 13 years ago, were resected due to a tumour implantation. The left phrenic nerve, the pericardium, and the diaphragm were all resected because of tumour invasion. The pericardium and the diaphragm were reconstructed with a polytetrafluoroethylene patch. The upper and lower mediastinal lymph nodes were dissected, and the EPP was completed with macroscopically complete resection. The operative time was 499 min, and the estimated blood loss was 1090 mL.
Figure 1

The preoperative chest computed tomography (CT). The CT image shows disseminated nodules in the left pleural cavity. We detected tumours that were adjacent to the pericardium, which indicated the possibility of pericardium invasion.

Figure 2

The preoperative fluorodeoxyglucose‐positron emission tomography (FDG‐PET) scan. The FDG‐PET scan showed significant dissemination in the left pleural cavity.

The preoperative chest computed tomography (CT). The CT image shows disseminated nodules in the left pleural cavity. We detected tumours that were adjacent to the pericardium, which indicated the possibility of pericardium invasion. The preoperative fluorodeoxyglucose‐positron emission tomography (FDG‐PET) scan. The FDG‐PET scan showed significant dissemination in the left pleural cavity. Histopathological examination revealed that the tumour was a type B2 thymoma, with direct invasion into the pericardium, the mediastinal fat tissue, the hilar lymph nodes, the third rib, and the intercostal muscle. However, exposure to the pericardial cavity or invasion into the cardiac muscle was not found (Fig. 3). The histopathological analysis also showed that there was no microscopical positive surgical margin, although it would be impossible to completely deny any positive margin in the specimen where the section was not made.
Figure 3

The pathological findings. The haematoxylin and eosin stain shows that the tumour was not exposed to the pericardial space (A) or the peritoneum (B).

The pathological findings. The haematoxylin and eosin stain shows that the tumour was not exposed to the pericardial space (A) or the peritoneum (B). The postoperative course was uneventful, except for persistent pain that required 37 days of hospitalization. She returned to her full‐time job at 9 months after surgery and showed no sign of recurrence at 31 months after surgery.

Discussion

Complete surgical resection is crucial for achieving a good survival outcome in patients with primary or recurrent thymoma 4. Okuda et al. reported that even in stage IVA thymoma cases with disseminated nodules, macroscopically complete resection yielded a better outcome 5. A few reports have demonstrated the efficacy of EPP for complete resection of pleural dissemination in selected cases 1, 2, 3. However, the indication of EPP as a radical surgery for pleural dissemination remains controversial. Okuda et al. 5 concluded that EPP should be utilized conservatively because of the high operative mortality and the low postoperative quality of life. Ishikawa et al. 1 and Write 2 claimed that patients undergoing EPP should be young and exhibit excellent cardiopulmonary function. Furthermore, patients with metastatic disease should be excluded, and if myasthenia gravis is present, it must be well controlled. Moreover, Fabre et al. 3 reported that good functional status with a predictive forced expiratory volume in 1 s (FEV1) value of >50% is required. In this case, the patient was young, lacked preoperative complications, had preoperative high levels of daily physical activity, and her pulmonary functional test was within the normal range. There have been few reports examining EPP for recurrent thymoma with pleural dissemination 1, 2, 3, 4. Most of the previous reports only described the survival or recurrence rates following EPP. They did not describe postoperative quality of life, general conditions, and daily activity levels in detail. The postoperative course of our patient was uneventful, and she returned to her full‐time job 9 months after surgery. This treatment may achieve a better prognosis with an acceptable postoperative quality of life if adequately utilized. As the primary treatment failed over 12 years, longer follow up would be mandatory following the second surgery. We conclude that young fit patients would tolerate EPP for recurrent thymoma with pleural dissemination.

Disclosure Statement

Appropriate written informed consent was obtained for publication of this case report and accompanying images.
  5 in total

1.  Surgical treatment of recurrent thymoma: is it worthwhile?†.

Authors:  Giuseppe Marulli; Stefano Margaritora; Marco Lucchi; Giuseppe Cardillo; Pierluigi Granone; Alfredo Mussi; Francesco Carleo; Egle Perissinotto; Federico Rea
Journal:  Eur J Cardiothorac Surg       Date:  2015-03-08       Impact factor: 4.191

2.  Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma.

Authors:  Cameron D Wright
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

3.  Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma.

Authors:  Dominique Fabre; Elie Fadel; Sacha Mussot; Olaf Mercier; Boriana Petkova; Benjamin Besse; James Huang; Philippe G Dartevelle
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-21       Impact factor: 4.191

4.  Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan.

Authors:  Katsuhiro Okuda; Motoki Yano; Ichiro Yoshino; Meinoshin Okumura; Masahiko Higashiyama; Kenji Suzuki; Masanori Tsuchida; Jitsuo Usuda; Hisashi Tateyama
Journal:  Ann Thorac Surg       Date:  2014-03-20       Impact factor: 4.330

5.  Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy.

Authors:  Yoshinori Ishikawa; Haruhisa Matsuguma; Rie Nakahara; Haruko Suzuki; Akiko Ui; Tetsuro Kondo; Yukari Kamiyama; Seiji Igarashi; Kiyoshi Mori; Tetsuro Kodama; Kohei Yokoi
Journal:  Ann Thorac Surg       Date:  2009-09       Impact factor: 4.330

  5 in total
  1 in total

Review 1.  [Treatment of Recurrent Thymoma].

Authors:  Xianping Liu; Xiao Li; Jianfeng Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.